Company profile: One Lambda
1.1 - Company Overview
Company description
- Provider of histocompatibility (HLA) typing tests using serological and molecular technologies, and manufacturer of antibody detection products, laboratory instrumentation, and computer software used to simplify and automate testing procedures.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to One Lambda
Allakos
HQ: United States
Website
- Description: Provider of therapeutic antibodies for allergy, inflammatory and proliferative diseases, including AK006, a humanized IgG1 monoclonal antibody targeting Siglec-6 to inhibit mast cell activation and reduce mast cell numbers via antibody-dependent cellular phagocytosis, and AK007, a humanized Siglec-10 antagonist that blocks ligand interaction to restore macrophage and dendritic cell anti-tumor activity and promote anti-tumor immunity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allakos company profile →
Genome Diagnostics
HQ: The Netherlands
Website
- Description: Provider of in vitro diagnostic tests and services, molecular diagnostic kits, analysis software, and education for transplantation and companion diagnostics. Delivers sequencing-based, high-resolution HLA typing for Sanger and NGS, NGSgo workflows, Oxford Nanopore solutions (NGS-Pronto, NGS-Turbo), NGSengine-Turbo software, and chimerism monitoring assays and software (NGStrack, TRKengine).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genome Diagnostics company profile →
Fresh Tracks Therapeutics
HQ: United States
Website
- Description: Provider of pharmaceutical therapeutics for autoimmune, inflammatory, and debilitating diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fresh Tracks Therapeutics company profile →
Sparrow Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapies for disorders of corticosteroid excess, including SPI-62, an oral HSD-1 inhibitor designed to reduce intracellular cortisol in conditions like endogenous Cushing’s syndrome and autonomous cortisol secretion, and SPI-47, combining SPI-62 with prednisolone for autoimmune diseases such as polymyalgia rheumatica.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sparrow Pharmaceuticals company profile →
Serimmune
HQ: United States
Website
- Description: Provider of antibody repertoire profiling and immune analytics via the Serum Epitope Repertoire Analysis (SERA) platform to identify disease-specific antigens and epitopes in a single assay; immune profiling with high-resolution epitope mapping and immune status reports; biomarker discovery across infectious diseases, cancer, and autoimmunity; Titan panel covering 50+ infectious diseases; and population serosurveillance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Serimmune company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for One Lambda
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to One Lambda
2.2 - Growth funds investing in similar companies to One Lambda
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for One Lambda
4.2 - Public trading comparable groups for One Lambda
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →